Latest news from Porter Novelli, New York on Newswise en-us Copyright 2024 Newswise 115 31 / /images/newswise-logo-rss.gif /articles/half-of-patients-with-active-early-rheumatoid-arthritis-achieved-clinical-remission/?sc=rsin /articles/half-of-patients-with-active-early-rheumatoid-arthritis-achieved-clinical-remission/?sc=rsin Thu, 08 Nov 2007 10:25:00 EST Amgen and Wyeth Pharmaceuticals today announced that data from a multicenter, randomized, double-blind trial of ENBREL plus methotrexate showed that 50 percent of patients with active early rheumatoid arthritis achieved clinical remission at one year. Porter Novelli, New York /articles/enbrel-safety-data-for-up-to-eight-years-in-patients-with-juvenile-rheumatoid-arthritis/?sc=rsin /articles/enbrel-safety-data-for-up-to-eight-years-in-patients-with-juvenile-rheumatoid-arthritis/?sc=rsin Wed, 13 Jun 2007 09:00:00 EST Amgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced the presentation of additional data that showed that the safety profile of ENBRELA(r) (etanercept) was maintained with long-term use in patients with moderate-to-severe juvenile rheumatoid arthritis (JRA) who completed up to eight years of therapy. Porter Novelli, New York /articles/survey-indicates-people-with-chronic-moderate-to-severe-plaque-psoriasis-may-be-under-treated/?sc=rsin /articles/survey-indicates-people-with-chronic-moderate-to-severe-plaque-psoriasis-may-be-under-treated/?sc=rsin Fri, 02 Feb 2007 14:00:00 EST The National Psoriasis Foundation and Amgen released data which show that nearly 40 percent of patients with chronic moderate to severe psoriasis are not currently receiving any treatment. Further, more than half of moderate to severe patients on treatment are not being treated in accordance with AAD guidelines, which state that patients diagnosed with chronic moderate to severe plaque psoriasis are candidates for phototherapy or systemic therapy, including biologic agents. Porter Novelli, New York /articles/katie-lee-joel-joins-kidney-friendly-comfort-foods-program-to-support-dialysis-patients/?sc=rsin /articles/katie-lee-joel-joins-kidney-friendly-comfort-foods-program-to-support-dialysis-patients/?sc=rsin Thu, 31 Aug 2006 08:00:00 EST Katie Lee Joel, the first season host of Bravo's hit, "Top Chef" and Shire Pharmaceuticals today announced Katie's participation in the company's Kidney Friendly Comfort Foods program, including her contribution of six recipes for the 2006 edition of the Kidney Friendly Comfort Foods: A Collection of Recipes for People with Chronic Kidney Disease. Porter Novelli, New York /articles/oct-14-web-cast-covering-vaccines-immunizations/?sc=rsin /articles/oct-14-web-cast-covering-vaccines-immunizations/?sc=rsin Mon, 11 Oct 2004 14:40:00 EST An important discussion about reporting on the complex world of vaccines, especially timely with last week's news of the influenza vaccine shortage. Porter Novelli, New York /articles/amgen-investigational-therapy-for-bone-loss-increased-bone-mineral-density/?sc=rsin /articles/amgen-investigational-therapy-for-bone-loss-increased-bone-mineral-density/?sc=rsin Sun, 03 Oct 2004 19:50:00 EST Amgen Inc. announced that at all doses studied, twice yearly injections of AMG 162, the company's investigational therapy for bone loss, significantly increased bone mineral density at the total hip compared with placebo at 12 months. Porter Novelli, New York /articles/fda-approves-enbrel-to-treat-psoriasis/?sc=rsin /articles/fda-approves-enbrel-to-treat-psoriasis/?sc=rsin Mon, 03 May 2004 08:00:00 EST Amgen and Wyeth Pharmaceuticals announced that Enbrel (etanercept) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with chronic moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy. Porter Novelli, New York /articles/fda-approves-baxters-advate-for-the-treatment-of-hemophilia-a/?sc=rsin /articles/fda-approves-baxters-advate-for-the-treatment-of-hemophilia-a/?sc=rsin Mon, 28 Jul 2003 13:00:00 EST Baxter Healthcare Corporation announced today that the FDA approved ADVATE (Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method) rAHF-PFM for the prevention and control of bleeding episodes in people with hemophilia A. Porter Novelli, New York /articles/new-insulin-injection-device-now-available/?sc=rsin /articles/new-insulin-injection-device-now-available/?sc=rsin Wed, 04 Sep 2002 00:00:00 EST Novolin InnoLet human insulin (rDNA origin) is designed to overcome the barriers to accurate dosing that are commonly associated with the vial and syringe method of insulin delivery, currently used by the majority of people in the United States taking insulin. Porter Novelli, New York /articles/venlafaxine-xr-first-snri-studied-for-social-anxiety-disorder/?sc=rsin /articles/venlafaxine-xr-first-snri-studied-for-social-anxiety-disorder/?sc=rsin Fri, 28 Jun 2002 00:00:00 EST People with social anxiety disorder (SAD), also known as social phobia, significantly reduced their fear, anxiety and related symptoms in four or six weeks of treatment with the extended release (XR) formulation of the antidepressant venlafaxine, the first available serotonin-norepinephrine reuptake inhibitor (SNRI), according to data from two studies. Porter Novelli, New York /articles/over-the-counter-or-prescription-nicotine-replacement-equally-good-for-smoking-cessation/?sc=rsin /articles/over-the-counter-or-prescription-nicotine-replacement-equally-good-for-smoking-cessation/?sc=rsin Fri, 26 Apr 2002 00:00:00 EST Nicotine replacement therapies, such as a skin patch or gum, when used by smokers on their own as over-the-counter medicines, safely yield smoking cessation success rates as good as when administered under a physician's prescription. Porter Novelli, New York /articles/new-patient-survey-puts-a-human-face-on-overcoming-depression/?sc=rsin /articles/new-patient-survey-puts-a-human-face-on-overcoming-depression/?sc=rsin Wed, 24 Apr 2002 00:00:00 EST The ability to fully engage in and enjoy family, personal and community activities is a critical milestone on the way to overcoming depression, according to the first survey to define treatment success through the eyes of people with depression. Porter Novelli, New York /articles/delta-burke-leads-goal-campaign-to-help-people-with-depression/?sc=rsin /articles/delta-burke-leads-goal-campaign-to-help-people-with-depression/?sc=rsin Wed, 24 Apr 2002 00:00:00 EST At the start of National Volunteer Week, Delta Burke, two-time Emmy Award nominated actress and long-time depression sufferer, announced a national awareness campaign called "GOAL! Go On And Live." Porter Novelli, New York /articles/increased-attempts-to-quit-smoking-follow-introduction-of-nicotine-replacement-therapies/?sc=rsin /articles/increased-attempts-to-quit-smoking-follow-introduction-of-nicotine-replacement-therapies/?sc=rsin Thu, 21 Feb 2002 00:00:00 EST Since nicotine replacement therapy became available as a nonprescription treatment to help Americans stop smoking, the number of adults attempting to quit smoking significantly increased to nearly 40 percent, according to a study of U.S. census data scheduled for presentation on Friday, Feb. 22, 2002 at the Eighth Annual Society for Research on Nicotine and Tobacco in Savannah, Ga. Porter Novelli, New York /articles/body-basics-quiz-educates-consumers-about-antioxidants/?sc=rsin /articles/body-basics-quiz-educates-consumers-about-antioxidants/?sc=rsin Sat, 04 Mar 2000 00:00:00 EST Guided by the cartooned members of Team AntioxidantSM, the Body Basics quiz enables parents, teachers and children to test their nutrition IQ and learn how vitamin C, vitamin E and the carotenoids impact different parts of the body. Porter Novelli, New York /articles/improving-cancer-care-research-and-treatment/?sc=rsin /articles/improving-cancer-care-research-and-treatment/?sc=rsin Fri, 04 Feb 2000 08:00:00 EST Government, patient advocacy, cancer research organization and corporate leaders will commit to the eradication of cancer by signing The Charter of Paris Against Cancer at the first World Summit Against Cancer, 3-4 Feb., in Paris, France. Porter Novelli, New York /articles/experts-available-for-october-national-lupus-awareness-month/?sc=rsin /articles/experts-available-for-october-national-lupus-awareness-month/?sc=rsin Sat, 02 Oct 1999 00:00:00 EST Speak with physician experts to learn more about the diagnosis, health impact and treatment of lupus. Learn more about an investigational lupus drug from Genelabs Technologies, Inc. Porter Novelli, New York /articles/online-campaign-encourages-better-breast-health/?sc=rsin /articles/online-campaign-encourages-better-breast-health/?sc=rsin Sat, 02 Oct 1999 00:00:00 EST Avon Products, Inc. announces the launch of its "Make the Promise" internet campaign, an online program that encourages women to take the steps toward breast cancer early detection and to urge friends and family to make breast health a top priority. Porter Novelli, New York /articles/baseball-players-come-out-swinging-against-tobacco-use/?sc=rsin /articles/baseball-players-come-out-swinging-against-tobacco-use/?sc=rsin Tue, 25 May 1999 00:00:00 EST At a United Nations press conference today, The Coalition for World No Tobacco Day unveiled its first major initiative to draw attention to World No Tobacco Day and the global tobacco epidemic. Porter Novelli, New York /articles/united-nations-press-conference-world-no-tobacco-day/?sc=rsin /articles/united-nations-press-conference-world-no-tobacco-day/?sc=rsin Sat, 22 May 1999 00:00:00 EST An esteemed group of non-profit organizations, corporate sponsors and renowned thought leaders have formed The Coalition for World No Tobacco Day, a group dedicated to raising awareness about tobacco-related death and disease worldwide and promoting a tobacco-free environment. Porter Novelli, New York